Skip to main content
Clinical Trials/TCTR20230316001
TCTR20230316001CompletedPhase 4

The development and efficacy testing of aggressive behavioral management among female schizophrenia

Prasrimahabhodi Psychiatric Hospital, Department of Mental Health, Ministry of Public Health0 sites30 target enrollmentStarted: March 16, 2023Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 Years to 70 Years (—)
Sex
Female

Inclusion Criteria

  • 1. Psychiatrists diagnosed schizophrenia following DSM-5
  • 2. No risk of suicide
  • 3. Assesed cognitive impairment by Mini-Mental State Examination over 21 score
  • 4. Assesed with Prasri Violent Severity Scale(PVSS) between 6-32 score
  • 5. Willing to participate in the research

Exclusion Criteria

  • 1. History of brain diseases or psychotics from the substance used
  • 2. Could not continually attend the program

Investigators

Sponsor
Prasrimahabhodi Psychiatric Hospital, Department of Mental Health, Ministry of Public Health

Similar Trials